LFCR logo

Lifecore Biomedical, Inc.

LFCR
Healthcare|Drug Manufacturers - Specialty & Generic|US
$6.36
-0.04 (-0.63%)
Cash / Share
$0.61
Next Earnings Report
Mar 15, 2027
EPS est. -$0.10 · Revenue est. $38.6M
Financing Filings (last 12 months)
0
No shelf registrations or offering prospectuses filed.

Upcoming Data Readouts (0)

No upcoming completion dates found in active trials.

Recent Press Releases

Lifecore Biomedical Reports Financial Results for the Third Quarter Ended September 30, 2026, and Provides Corporate Update
Nov 4, 2026 · GlobeNewsWire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: ADT Inc. (NYSE – ADT), RXO Inc. (NYSE – RXO), PTC Inc. (Nasdaq – PTC), Lifecore Biomedical, Inc. (Nasdaq – LFCR)
Oct 30, 2026 · GlobeNewsWire
Lifecore Biomedical to Participate at Upcoming Industry Conferences
Oct 7, 2026 · GlobeNewsWire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RXO Inc. (NYSE – RXO), PTC Inc. (Nasdaq – PTC), Lifecore Biomedical, Inc. (Nasdaq – LFCR), WaFd, Inc. (Nasdaq – WAFD)
Oct 5, 2026 · GlobeNewsWire
Halper Sadeh LLC is Investigating Whether LFCR and SSTI are Obtaining Fair Deals for their Shareholders
Sep 30, 2026 · GlobeNewsWire
Lifecore Biomedical Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Lifecore Biomedical, Inc. - LFCR
Sep 30, 2026 · Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Capital Bancorp, Inc. (Nasdaq – CBNK), Lifecore Biomedical, Inc. (Nasdaq – LFCR), MISTRAS Group, Inc. (NYSE – MG), Utz Brands, Inc. (NYSE – UTZ)
Sep 30, 2026 · GlobeNewsWire
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Lifecore Biomedical, Inc. (NASDAQ: LFCR)
Sep 29, 2026 · PRNewsWire
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Lifecore Biomedical, Inc. (LFCR)
Sep 29, 2026 · Newsfile Corp
LFCR SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER BUYOUT FAIRLY VALUES LIFECORE BIOMEDICAL, INC.
Sep 28, 2026 · PRNewsWire

SEC Filings (62)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 5, 2026DEFA14AProxy / shareholder voteDocumentIndex
Nov 5, 20268-KMaterial eventDocumentIndex
Nov 4, 202610-QQuarterly reportDocumentIndex
Nov 4, 20268-KMaterial eventDocumentIndex
Oct 30, 2026PREM14ADocumentIndex
Oct 20, 20268-KMaterial eventDocumentIndex
Sep 29, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Sep 29, 20268-KMaterial eventDocumentIndex
Sep 28, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Sep 28, 2026DEFA14AProxy / shareholder voteDocumentIndex
Sep 28, 20268-KMaterial eventDocumentIndex
Aug 5, 202610-QQuarterly reportDocumentIndex
Aug 5, 20268-KMaterial eventDocumentIndex
Jul 29, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jul 2, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Jul 2, 20268-KMaterial eventDocumentIndex
Jul 2, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Jun 5, 20268-KMaterial eventDocumentIndex
May 6, 202610-QQuarterly reportDocumentIndex
May 6, 20268-KMaterial eventDocumentIndex
Apr 27, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Apr 24, 2026DEF 14AProxy / shareholder voteDocumentIndex
Mar 16, 202610-KTAnnual reportDocumentIndex
Mar 16, 20268-KMaterial eventDocumentIndex
Mar 5, 20268-KMaterial eventDocumentIndex
Jan 21, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jan 16, 20268-KMaterial eventDocumentIndex
Nov 17, 20258-KMaterial eventDocumentIndex
Nov 6, 202510-QQuarterly reportDocumentIndex
Nov 6, 20258-KMaterial eventDocumentIndex
Oct 31, 20258-KMaterial eventDocumentIndex
Oct 17, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Sep 30, 2025EFFECTDocumentIndex
Sep 30, 2025424B3Offering prospectusDocumentIndex
Sep 26, 20258-KMaterial eventDocumentIndex
Sep 23, 2025S-3Shelf registrationDocumentIndex
Sep 18, 2025DEF 14AProxy / shareholder voteDocumentIndex
Aug 18, 20258-KMaterial eventDocumentIndex
Aug 12, 20258-KMaterial eventDocumentIndex
Aug 7, 2025S-8Employee stock planDocumentIndex